Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin.
about
Structure of the Human Protein Kinase ZAK in Complex with VemurafenibActivation of the Classical Mitogen-Activated Protein Kinases Is Part of the Shiga Toxin-Induced Ribotoxic Stress Response and May Contribute to Shiga Toxin-Induced Inflammation.Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs: synergistic effects of doxorubicin and vincristine.BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling.A Novel Zak Knockout Mouse with a Defective Ribotoxic Stress Response.A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles.Time-of-Day Dictates Transcriptional Inflammatory Responses to Cytotoxic Chemotherapy.A role for orexin in cytotoxic chemotherapy-induced fatigue.Inflammation and neural signaling: etiologic mechanisms of the cancer treatment-related symptom cluster.The role of IL-1β and TNF-α signaling in the genesis of cancer treatment related symptoms (CTRS): a study using cytokine receptor-deficient mice.Sorafenib suppresses JNK-dependent apoptosis through inhibition of ZAK.The flip side of doxorubicin: Inflammatory and tumor promoting cytokines.Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts.Doxorubicin induces ZAKα overexpression with a subsequent enhancement of apoptosis and attenuation of survivability in human osteosarcoma cells.Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.Diazoxide Improves Mitochondrial Connexin 43 Expression in a Mouse Model of Doxorubicin-Induced Cardiotoxicity.Amelioration of experimentally induced diabetic nephropathy and renal damage by nilotinib.
P2860
Q27704282-8EFE6F45-7D65-4AA4-99BA-FE08A0E55E9DQ33426863-A22EF68B-92A6-44A8-B03A-21D4EE88D73FQ34036124-61CD4985-E39E-4797-AC1E-A688E6196F52Q37271732-2280A911-75DD-42EB-953A-5BE02848B640Q37285664-777E0613-CA26-4EB2-8045-D034D9BA491AQ37513287-FA09DCE8-73CF-4289-8051-2B12F9C15C80Q37602119-9FADD56E-6D72-4D55-A7C6-A0AAFA51633AQ37633462-287C6777-D5ED-4F4E-BD86-4B1B5AA047BFQ37633785-6034BD1B-6CAB-41E3-9ECE-14C76D1150E3Q37707075-3F9540BC-893B-4FA4-AE2D-2407DBA16366Q39068901-37F68C5C-F4A1-4AAB-955E-A1D81A58B070Q41905184-4467B1FF-5482-4330-871B-BB002810E037Q42361616-05BF453F-598B-40A9-988D-466A97DAF59EQ47438375-D6E241B8-B474-48FE-A387-8462BDB9C3E2Q47980269-672923AF-696A-4665-B4CC-BB2B78520D31Q51742732-C0E4F02C-5443-4AE8-8BAC-F7932A2919A5Q53371980-0585129F-3451-4C32-93BB-5C4B3B778F8F
P2860
Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Small molecule kinase inhibito ...... matory effects of doxorubicin.
@ast
Small molecule kinase inhibito ...... matory effects of doxorubicin.
@en
type
label
Small molecule kinase inhibito ...... matory effects of doxorubicin.
@ast
Small molecule kinase inhibito ...... matory effects of doxorubicin.
@en
prefLabel
Small molecule kinase inhibito ...... matory effects of doxorubicin.
@ast
Small molecule kinase inhibito ...... matory effects of doxorubicin.
@en
P2093
P2860
P356
P1476
Small molecule kinase inhibito ...... matory effects of doxorubicin.
@en
P2093
Bruce E Magun
Cheleste M Thorpe
Dakshina M Jandhyala
Eli A Magun
Kirsten Kelley-Howard
Logan B Smith
Thomas Engstrom
P2860
P356
10.4161/CBT.22628
P577
2012-10-31T00:00:00Z